Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases

Clinical and Experimental Immunology

Volumn 165, Issue 1, 2011, Pages 44-50

  Marzano, A V ^a   Tedeschi, A ^a   Berti, E ^a   Fanoni, D ^a   Crosti, C ^a   Cugno, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Bullous pemphigoid; Eosinophil; Hypercoagulability; Skin diseases; Tissue factor

Indexed keywords

ANTI BP180 ANTIBODY; ANTIBODY; D DIMER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; BLISTER; BLOOD CLOTTING; BLOOD SAMPLING; BULLOUS PEMPHIGOID; CHRONIC URTICARIA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DERMATITIS HERPETIFORMIS; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHIL COUNT; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; SKIN INFLAMMATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOANTIGENS; BLOOD COAGULATION; CELL COUNT; DISEASE PROGRESSION; EOSINOPHILS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INFLAMMATION; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BULLOUS; PEPTIDE FRAGMENTS; PROTHROMBIN; SKIN NEOPLASMS; THROMBOPLASTIN;

EID: 79958144456     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04391.x     Document Type: Article

References (34)

1. Moosbauer C, Morgenstern E, Cuvelier SL etal. Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood 2007; 109:995-1002.
2. Marzano AV, Tedeschi A, Fanoni D etal. Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications. Br J Dermatol 2009; 160:266-72.
3. Borrego L, Maynard B, Peterson EA etal. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins. Am J Pathol 1996; 148:897-909.
4. Yancey KB. The pathophysiology of autoimmune blistering diseases. J Clin Invest 2005; 115:825-8.
5. Ujiie H, Shibaki A, Nishie W, Shimizu H. What's new in bullous pemphigoid. J Dermatol 2010; 37:194-204.
6. Marzano AV, Tedeschi A, Spinelli D, Fanoni D, Crosti C, Cugno M. Coagulation activation in autoimmune bullous diseases. Clin Exp Immunol 2009; 158:31-6.
7. Roujeau JC, Lok C, Bastuji-Garin S, Mhalla S, Enginger V, Bernard P. High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol 1998; 134:465-9.
8. Joly P, Benichou J, Lok C etal. Prediction of survival for patients with bullous pemphigoid: a prospective study. Arch Dermatol 2005; 141:691-8.
9. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994; 83:2759-79.
10. Ogbogu P, Rosing DR, Horne MK III. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007; 27:457-75.
11. Frezzolini A, Cianchini G, Ruffelli M, Cadoni S, Puddu P, De Pità O. Interleukin-16 expression and release in bullous pemphigoid. Clin Exp Immunol 2004; 137:595-600.
12. Budinger L, Borradori L, Yee C etal. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest 1998; 102:2082-9.
13. Frezzolini A, Teofoli P, Cianchini G etal. Increased expression of eotaxin and its specific receptor CCR3 in bullous emphigoid. Eur J Dermatol 2002; 12:27-31.
14. Niimi Y, Pawankar R, Kawana S. Increased expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and matrix metalloproteinase-13 in lesional skin of bullous pemphigoid. Int Arch Allergy Immunol 2006; 139:104-13.
15. Shimanovich I, Mihai S, Oostingh GJ etal. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J Pathol 2004; 204:519-27.
16. Ståhle-Bäckdahl M, Inoue M, Guidice GJ, Parks WC. 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. J Clin Invest 1994; 93:2022-30.
17. Cugno M, Tedeschi A, Asero R, Meroni PL, Marzano AV. Skin autoimmunity and blood coagulation. Autoimmunity 2010; 43:189-94.
18. DeMichele MA, Moon DG, Fenton JW 2nd, Minnear FL. Thrombin's enzymatic activity increases permeability of endothelial cell monolayers. J Appl Physiol 1990; 69:1599-606.
19. Cugno M, Tedeschi A, Crosti C, Marzano AV. Activation of blood coagulation in autoimmune skin disorders. Exp Rev Clin Immunol 2009; 5:605-13.
20. Lippi G, Montagnana M, Salvagno GL, Franchini M, Targher G, Guidi GC. Eosinophilia and first-line coagulation testing. J Thromb Thrombolysis 2009; 28:90-3.
21. Asero R, Tedeschi A, Riboldi P, Cugno M. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol 2006; 117:1113-7.
22. Asero R, Tedeschi A, Coppola R etal. Activation of the tissue pathway of blood coagulation in patients with chronic urticaria. J Allergy Clin Immunol 2007; 119:705-10.
23. Asero R, Tedeschi A, Riboldi P, Griffini S, Bonanni E, Cugno M. Severe chronic urticaria is associated with elevated plasma levels of D-dimer. Allergy 2008; 63:176-80.
24. Cugno M, Marzano AV, Asero R, Tedeschi A. Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications. Intern Emerg Med 2010; 5:97-101.
25. Cugno M, Marzano AV, Tedeschi A, Fanoni D, Venegoni L, Asero R. Expression of tissue factor by eosinophils in patients with chronic urticaria. Int Arch Allergy Immunol 2009; 148:170-4.
26. Oyoshi MK, He R, Kumar L, Yoon J, Geha RS. Cellular and molecular mechanisms in atopic dermatitis. Adv Immunol 2009; 102:135-226.
27. Patrício P, Ferreira C, Gomes MM, Filipe P. Autoimmune bullous dermatoses: a review. Ann NY Acad Sci 2009; 1173:203-10.
28. Caproni M, Cardinali C, D'Agata A, Selvaggi W, Fabbri P. Serum eosinophil cationic protein, myeloperoxidase, tryptase, eotaxin and Th2-L-like cytokines in dermatitis herpetiformis. Int Arch Allergy Immunol 2002; 128:67-72.
29. Cox NH, Friedmann PS. Induction of lesions of dermatitis herpetiformis by autologous serum. Br J Dermatol 1991; 124:69-73.
30. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009; 361:496-509.
31. Marongiu F, Sorano GG, Bibbò C etal. Abnormalities of blood coagulation and fibrinolysis in psoriasis. Dermatology 1994; 189:32-7.
32. So AK, Varisco PA, Kemkes-Matthes B etal. Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. J Thromb Haemost 2003; 1:2510-5.
33. Kume K, Yamasaki M, Tashiro M etal. Activations of coagulation and fibrinolysis secondary to bowel inflammation in patients with ulcerative colitis. Intern Med 2007; 46:1323-9.
34. Liaw PC, Esmon CT, Kahnamoui K etal. Patients with severe sepsis vary markedly in their ability to generate activated protein C. Blood 2004; 104:3958-64.